SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 96 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $536,796 | +1062.4% | 68,820 | +517.0% | 0.01% | +800.0% |
| Q1 2024 | $46,178 | -16.3% | 11,154 | -47.2% | 0.00% | 0.0% |
| Q4 2023 | $55,186 | +336.6% | 21,144 | +212.8% | 0.00% | – |
| Q3 2023 | $12,641 | +2.7% | 6,760 | +37.9% | 0.00% | – |
| Q2 2023 | $12,304 | +34077.8% | 4,902 | -76.5% | 0.00% | -100.0% |
| Q1 2023 | $36 | -68.7% | 20,874 | -22.9% | 0.00% | -80.0% |
| Q4 2022 | $115 | -99.2% | 27,080 | +137.7% | 0.01% | – |
| Q3 2022 | $14,000 | +55.6% | 11,391 | +21.7% | 0.00% | – |
| Q2 2022 | $9,000 | -10.0% | 9,363 | +124.2% | 0.00% | – |
| Q1 2022 | $10,000 | -9.1% | 4,176 | +2.3% | 0.00% | – |
| Q4 2021 | $11,000 | -8.3% | 4,081 | +73.0% | 0.00% | – |
| Q3 2021 | $12,000 | -53.8% | 2,359 | -31.3% | 0.00% | -100.0% |
| Q2 2021 | $26,000 | -7.1% | 3,436 | -28.7% | 0.00% | – |
| Q1 2021 | $28,000 | +55.6% | 4,817 | +27.3% | 0.00% | -100.0% |
| Q4 2020 | $18,000 | – | 3,783 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 23,222,222 | $181,133,332 | 2.32% |
| Anson Funds Management LP | 941,908 | $7,346,882 | 0.88% |
| QVT Financial LP | 575,705 | $4,490,499 | 0.42% |
| Wealth Management Partners, LLC | 42,000 | $327,600 | 0.16% |
| Pinpoint Asset Management Ltd | 120,746 | $941,819 | 0.13% |
| VANCE WEALTH, INC. | 39,266 | $306,275 | 0.13% |
| Sargent Investment Group, LLC | 72,000 | $561,600 | 0.12% |
| China Universal Asset Management Co., Ltd. | 82,473 | $643,289 | 0.09% |
| Caption Management, LLC | 723,700 | $5,644,860 | 0.09% |
| SECTORAL ASSET MANAGEMENT INC | 25,000 | $195,000 | 0.08% |